President and COO
Celgene Corporation
Mr. Smith was promoted to President and Chief Operating Officer on April 1, 2017. Previously, he was President, Global Inflammation & Immunology (I&I). Mr. Smith joined Celgene in 2008 as Vice President, Global Marketing I&I and was subsequently named Senior Vice President, Global Head of I & I. From 2003 to 2008 Mr. Smith was with Biovail, holding positions of General Manager Biovail U.S., General Manager Biovail Canada and Global Commercial Head. As Global Commercial Head, he was responsible for revenue generation, commercial strategies, business development strategy, and input into regulatory and clinical development strategies. Prior to Biovail, Mr. Smith was with Pharmacia (formerly Upjohn) for 16 years where he held various positions including Vice President U.S. Sales, Vice President Marketing Europe based in Paris, Vice President and Commercial Lead for Canada based in Toronto, and Commercial and Regulatory Head for South East Asia based in Hong Kong. In January 2017, Mr. Smith was named a Director of Titan Pharmaceuticals, a specialty pharmaceuticals company that develops therapeutics for select chronic diseases utilizing its innovative, long-term, continuous drug delivery platform, ProNeura. Mr. Smith holds a BSc in Chemistry and an HBSc in Pharmacology and Toxicology from the University of Western Ontario and a Masters of International Business Management from the American Graduate School of International Management (Thunderbird).
None yet.